Clinical Trials Directory

Trials / Completed

CompletedNCT02540447

Purge Vs no Purge in Living Donor Liver Transplantation Recipients

Graft Portal Reperfusion Without Purging Graft Preservative Solution In Living Donor Liver Transplantation. A Prospective Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The investigators tested the impact of purging the graft contents and mesenteric blood into the systemic circulation versus washing out this volume out of the circulation in living donor liver transplantation recipients.

Detailed description

All donors had right hepatectomy. On the back table, surgeons flushed liver grafts with 4 Liters of cold Custodiol solution. Patients were randomized into either purge group (Pg) (n=40) were graft fluid contents were washed out by the patient's portal vein blood (0.5ml per gram graft weight) through incompletely anastomosed hepatic vein, or No purge group (NPg) (n=40) where graft fluid contents were washed into the systemic circulation by the patient's portal blood. The primary outcome objective was the mean arterial blood pressure 5 minutes after portal declamping. Secondary objectives included hemodynamic and oxygenation.

Conditions

Interventions

TypeNameDescription
PROCEDUREPurgeIn the recipient before portal declamping, the graft preservative solution and the mesenteric blood is washed out of the circulation into the abdominal cavity and sucked by external sucker through the incompletely anastomosed hepatic vein prior to portal declamping

Timeline

Start date
2013-01-01
Primary completion
2014-05-01
Completion
2015-05-01
First posted
2015-09-04
Last updated
2017-04-26
Results posted
2015-10-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02540447. Inclusion in this directory is not an endorsement.